Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.99 USD | -2.61% | +5.06% | +58.89% |
Jun. 11 | Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target | MT |
May. 29 | Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 24.70 | 24.70 | 23.94 |
Spread/Res. | -10.97% | -10.97% | -8.15% |
Spread/Supp. | +31.05% | +31.05% | +37.61% |
Support | 16.78 | 16.78 | 15.98 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ELVN Stock
- Charts Enliven Therapeutics, Inc.